Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-11-01 14:44 Tx date 2023-10-30 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Riesenfeld, Gadi
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,200 vol |
129,200 | |
Filed 2023-11-01 14:38 Tx date 2023-07-06 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Riesenfeld, Gadi
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-06-23 15:23 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,176
+129,200 vol $0.28 each |
||
Filed 2023-06-13 16:33 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,176
+129,200 vol $0.28 each |
||
Filed 2023-06-13 16:33 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,176
+129,200 vol $0.28 each |
258,400 | |
Filed 2023-05-11 14:30 Tx date 2023-05-09 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,176
+129,200 vol $0.28 each |
129,200 | |
Filed 2023-05-09 18:10 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
1,104,320 | |
Filed 2023-05-09 18:09 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 18:08 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 18:08 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
||
Filed 2023-05-09 18:06 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
497,200 | |
Filed 2023-05-09 18:05 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 18:04 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 18:04 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
Filed 2023-05-09 18:02 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
762,995 | |
Filed 2023-05-09 18:01 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 18:00 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 17:59 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
Filed 2023-05-09 17:57 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,200 vol |
129,200 | |
Filed 2023-05-09 17:56 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,200 vol |
||
Filed 2023-05-09 15:19 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,200 vol |
129,200 | |
Filed 2023-05-09 15:19 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+129,200 vol |
||
Filed 2023-05-09 14:32 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-09 14:30 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
||
Filed 2023-05-09 14:30 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
1,104,320 | |
Filed 2023-05-09 14:29 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 14:29 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 14:28 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-09 14:25 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
762,995 | |
Filed 2023-05-09 14:25 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
Filed 2023-05-09 14:24 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 14:24 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 14:23 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-09 14:19 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
497,200 | |
Filed 2023-05-09 14:19 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
Filed 2023-05-09 14:18 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 14:18 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 14:16 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-07-26 12:29 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-135,000 vol |
70,000 | |
Filed 2022-07-26 12:26 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
-1,845,000 vol |
205,000 |